Your browser doesn't support javascript.
loading
Cross protective efficacy of the Non-Neurotropic live attenuated herpes simplex virus type 1 vaccine VC-2 is enhanced by intradermal vaccination and deletion of glycoprotein G.
Stanfield, Brent A; Bravo, Fernando J; Dixon, David A; Chouljenko, Vladimir N; Kousoulas, Konstantin G; Bernstein, David I.
Afiliação
  • Stanfield BA; Division of Biotechnology and Molecular Medicine and Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, USA.
  • Bravo FJ; Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA.
  • Dixon DA; Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA.
  • Chouljenko VN; Division of Biotechnology and Molecular Medicine and Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, USA.
  • Kousoulas KG; Division of Biotechnology and Molecular Medicine and Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, USA.
  • Bernstein DI; Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA. Electronic address: david.bernstein@cchmc.org.
Vaccine ; 40(42): 6093-6099, 2022 10 06.
Article em En | MEDLINE | ID: mdl-36114130

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Herpes Genital / Herpesvirus Humano 1 / Vacinas contra o Vírus do Herpes Simples / Herpes Simples Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Herpes Genital / Herpesvirus Humano 1 / Vacinas contra o Vírus do Herpes Simples / Herpes Simples Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos